Company Filing History:
Years Active: 1989-1990
Title: The Innovations of Richard A. Kenley
Introduction
Richard A. Kenley is a notable inventor based in Libertyville, IL (US). He has made significant contributions to the field of chemistry, particularly in the development of compounds that can counteract the effects of organophosphorus poisoning. With a total of 2 patents to his name, Kenley's work is both innovative and impactful.
Latest Patents
Kenley's latest patents include the development of aldoxime-substituted imidazolium derivatives. These compounds are therapeutically effective in treating living species poisoned by organophosphorus chemicals, which inhibit the enzyme acetylcholinesterase. His research has shown that in vivo administration of these derivatives can save mammals that have been exposed to lethal doses of Soman. Additionally, he has developed aldoxime-substituted triazolium compounds, which also demonstrate effectiveness in treating similar poisoning cases in mice.
Career Highlights
Kenley is associated with SRI International, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in medical and environmental safety.
Collaborations
Some of his notable coworkers include Ralph New Harris, III and Clifford D. Bedford. Their collaborative efforts have contributed to the success of Kenley's research and the development of his patented compounds.
Conclusion
Richard A. Kenley is a distinguished inventor whose work in developing antidotes for organophosphorus poisoning showcases his commitment to innovation and public health. His contributions are vital in the ongoing fight against chemical threats.